- Home
- CMLS vs EDSA Comparison
CMLS vs EDSA Comparison
Compare CMLS & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMLS
- EDSA
- Stock Information
- Founded
- CMLS 2002
- EDSA 2015
- Country
- CMLS United States
- EDSA Canada
- Employees
- CMLS N/A
- EDSA N/A
- Industry
- CMLS Broadcasting
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CMLS Consumer Discretionary
- EDSA Health Care
- Exchange
- CMLS Nasdaq
- EDSA Nasdaq
- Market Cap
- CMLS 7.7M
- EDSA 6.2M
- IPO Year
- CMLS 1998
- EDSA N/A
- Fundamental
- Price
- CMLS $0.43
- EDSA $2.30
- Analyst Decision
- CMLS
- EDSA Strong Buy
- Analyst Count
- CMLS 0
- EDSA 1
- Target Price
- CMLS N/A
- EDSA $21.00
- AVG Volume (30 Days)
- CMLS 462.0K
- EDSA 23.4K
- Earning Date
- CMLS 05-02-2025
- EDSA 05-09-2025
- Dividend Yield
- CMLS N/A
- EDSA N/A
- EPS Growth
- CMLS N/A
- EDSA N/A
- EPS
- CMLS N/A
- EDSA N/A
- Revenue
- CMLS $827,076,000.00
- EDSA N/A
- Revenue This Year
- CMLS N/A
- EDSA N/A
- Revenue Next Year
- CMLS $0.79
- EDSA N/A
- P/E Ratio
- CMLS N/A
- EDSA N/A
- Revenue Growth
- CMLS N/A
- EDSA N/A
- 52 Week Low
- CMLS $0.41
- EDSA $1.55
- 52 Week High
- CMLS $3.34
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- CMLS 37.99
- EDSA 47.13
- Support Level
- CMLS $0.43
- EDSA $2.31
- Resistance Level
- CMLS $0.51
- EDSA $2.54
- Average True Range (ATR)
- CMLS 0.07
- EDSA 0.11
- MACD
- CMLS 0.01
- EDSA -0.03
- Stochastic Oscillator
- CMLS 23.02
- EDSA 3.45
Stock Price Comparison Chart: CMLS vs EDSA
About CMLS Cumulus Media Inc.
Cumulus Media Inc is an audio-first media company delivering content to over a quarter billion people monthly whenever required. It is a radio broadcasting company combining high-quality local programming with iconic, nationally syndicated media, sports, and entertainment brands to deliver premium content choices to its customers and radio stations affiliated with the Westwood One network and numerous digital channels. The company's revenue is derived from Broadcast radio revenue, Digital revenue, and Other revenue.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.